Nextgen Total Liabilities

Latest as of June 2025: ILA11.20 Million ILA ≈ $30.02K USD

Nextgen total liabilities. Based on the latest financial reports, Nextgen (NXGN) has total liabilities worth ILA11.20 Million ILA (≈ $30.02K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Nextgen defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Nextgen (2008–2024)

Total liabilities of Nextgen from 2008 to 2024. This chart illustrates how Nextgen's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Nextgen's assets to evaluate the company's liquid asset resilience ratio.

Nextgen Competitors by Total Liabilities

The table below lists competitors of Nextgen ranked by their total liabilities.

Company Country Total Liabilities
Foxtons Group Plc
LSE:FOXT
UK GBX133.11 Million
Astron Paper & Board Mill Limited
NSE:ASTRON
India Rs1.26 Billion
Vault Strategic Mining Corp.
V:KNOX
Canada CA$1.13 Million
Gabather AB (publ)
ST:GABA
Sweden Skr4.20 Million
Vanquis Banking Group PLC
LSE:VANQ
UK GBX3.45 Billion
Quartix Holdings Plc
LSE:QTX
UK GBX11.00 Million
Link Bilgisayar Sistemleri Yazilimi ve Donanimi Sanayi ve Ticaret AS
IS:LINK
Turkey TL497.79 Million

Liability Composition Analysis (2008–2024)

This chart breaks down Nextgen's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NXGN total assets.

Liquidity & Leverage Metrics

Nextgen Total Liabilities Ratios Explained

Nextgen total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.05 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.35 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 7.56 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nextgen's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nextgen (2008–2024)

The table below shows the annual total liabilities of Nextgen from 2008 to 2024.

Year Total Liabilities Change
2024-12-31 ILA3.04 Million
≈ $8.15K
+145.16%
2023-12-31 ILA1.24 Million
≈ $3.32K
-52.99%
2022-12-31 ILA2.64 Million
≈ $7.07K
-9.69%
2021-12-31 ILA2.92 Million
≈ $7.83K
+101.17%
2020-12-31 ILA1.45 Million
≈ $3.89K
+90.80%
2019-12-31 ILA761.00K
≈ $2.04K
+4.25%
2018-12-31 ILA730.00K
≈ $1.96K
+5.34%
2017-12-31 ILA693.00K
≈ $1.86K
-19.04%
2016-12-31 ILA856.00K
≈ $2.29K
+16.46%
2015-12-31 ILA735.00K
≈ $1.97K
-82.53%
2014-12-31 ILA4.21 Million
≈ $11.28K
+306.96%
2013-12-31 ILA1.03 Million
≈ $2.77K
+903.88%
2012-12-31 ILA103.00K
≈ $276.14
-43.09%
2011-12-31 ILA181.00K
≈ $485.25
-64.16%
2010-12-31 ILA505.00K
≈ $1.35K
+113.98%
2008-12-31 ILA236.00K
≈ $632.71
--

About Nextgen

TA:NXGN Israel Medical Instruments & Supplies
Market Cap
$1.32 Million
ILA490.55 Million ILA
Market Cap Rank
#30467 Global
#445 in Israel
Share Price
ILA45.00
Change (1 day)
+17.19%
52-Week Range
ILA37.60 - ILA68.40
All Time High
ILA25020.00
About

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.